In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.
Orca-T improved 1-year survival without severe graft-vs-host disease compared with standard transplant in the Precision-T ...
Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...
Working with mouse cells, the researchers developed a highly efficient conversion method that can produce more than 10 ...
A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.
In a ceremony held last month, the 2024 Louisa Gross Horwitz Prize was awarded to Wesley Sundquist, PhD, Leo T. and Barbara K ...
Converting one type of cell to another—for example, a skin cell to a neuron—can be done through a process that requires the ...
A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according ...
A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study. The discovery could lead ...
Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.
We explored this hypothesis in a cnidarian Hydra model system, in which spontaneous tumors can occur in the lab, and lineages in which such neoplastic cells are vertically transmitted (through host ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results